2024 Key Results

Marketing Strategy

Led comprehensive analyses to provide strategic recommendations to help multiple clients select launch or expansion strategies into traditional and alternate channels
Created naming and packaging design elements, including structure, function, and correct use instructions for a first-in-class OTC product
Created best-in-class commercialization strategies and detailed required capabilities for 5 companies entering the CHC industry
Developed company portfolio, branding, and expansion strategies for multiple clients
Served as senior marketing resources for multiple brands, including leading DTC, e-commerce, digital, and social media marketing
Created and validated innovation concepts, plus retailer sell-in decks for several brands
Uncovered unmet needs via thought leader conversations to build marketing strategy for a new consumer diagnostic product
Provided analysis and thought leadership for Amazon activation strategies as well as Amazon’s emerging healthcare strategy

Business Development

Led the divestiture process of six brands for four different consumer healthcare companies as well as technology divestitures
Led proactive acquisition strategies, evaluated hundreds of potential target brands, provided recommendations, and helped acquire assets for four clients
Conducted acquisition due diligence on a range of opportunities and categories
Deeply investigated various go-to-market business models, such as DTC, brick-and-mortar, and Amazon, to determine the most profitable commercialization strategy for multiple clients
Helped consumer health organizations identify manufacturing sources
Identified strategic growth opportunities and organizational requirements for Private Label manufacturers

Rx-to-OTC Switch

Led strategic development to progress four Rx-to-OTC switches
Initiated research collaboration for a company pursuing ACNU with other industry partners seeking to learn from their experience
Performed robust analyses of the Rx-to-OTC switch landscape for numerous clients to enable investment decisions
Created clinical program cost and timing plan as well as provided pIND support for Rx-to-OTC switches
Identified and met with potential partners for clients seeking to out-license Rx-to-OTC switch products
Deeply analyzed past switches to guide clients about best practices, investment needs, and organizational skills requirements
Identified high potential future switches and coordinated meetings with asset holders for multiple clients
Demonstrated thought leadership through CHPA leadership, numerous podcasts, and speaking engagements